普通外文研报
Kroger Co.: Q1'26 Preview: New Balancing Act
研报英文原文证据摘录
Kroger Co.: Q1'26 Preview: New Balancing Act
UpdateMconfidence in KR's ability to claw back market share while still protecting the
overall P&L and '26 guidance.
• Scenario 2: The "Show Me" Investment Cycle (-). KR's FIFO gross margin
faces tens of bps of pressure y/y due to a step-up in price investments that
are not fully self-funded, and this occurs prior to the realization of market
share gains. In this scenario, we think the stock reaction would be negative as
the equity story moves into a "show me" mode where KR will only get credit
for its strategy once share gains become more visible.
• Scenario 3: Threading the Needle (+/-). KR's FIFO gross margin faces slight
pressure y/y but is largely stable, while IDs ex-fuel grow near +1% and the
magnitude & timing of additional price investments throughout '26 is left
open-ended. In this scenario, our instinct is the stock will face pressure as
there is risk the degree of price investments will not be enough to drive
meaningful share gains, yet gross margin still declines y/y in '26. That said,
we see an upside case in which KR is able to provide enough detail on the
source of funds for the investments which assuages these concerns.
Q1'26 Preview:
Expecting in-line IDs ex-fuel of +1.0%. Per Nielsen, industry sales for the period
aligned with KR's fiscal Q1 grew +2.0% y/y. Applying a ~100 bps spread between
industry sales and KR's IDs ex-fuel implies +1.0% growth, which is in-line with the
consensus estimate of +1.1%. We believe a ~100 bps spread is appropriate as KR has
cycled the benefits from outsized pharmacy growth in 2025 (driven by both existing
customers fulfilling more scripts as well as new customer growth due to competitor
closures) which narrowed KR's spread to slightly positive levels ( Exhibit 1 ). In
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器